Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | PLoS Neglected Tropical Diseases | journal | 2.669 Q1 | 163 | 854 | 2584 | 41239 | 12295 | 2529 | 4.62 | 48.29 | 42.06 | |
2 | Molecular Therapy - Nucleic Acids | journal | 2.011 Q1 | 95 | 213 | 329 | 11528 | 1934 | 321 | 5.46 | 54.12 | 41.52 | |
3 | PPAR Research | journal | 1.605 Q1 | 59 | 19 | 79 | 1024 | 374 | 77 | 4.27 | 53.89 | 52.99 | |
4 | Cancer Biology and Therapy | journal | 1.240 Q1 | 130 | 148 | 476 | 5074 | 1527 | 468 | 2.94 | 34.28 | 42.24 | |
5 | Cancer Nanotechnology | journal | 1.220 Q1 | 36 | 11 | 24 | 564 | 133 | 21 | 5.81 | 51.27 | 43.10 | |
6 | Life Sciences | journal | 1.017 Q1 | 191 | 649 | 1202 | 36375 | 4240 | 1194 | 3.63 | 56.05 | 44.10 | |
7 | Human Vaccines and Immunotherapeutics | journal | 0.989 Q2 | 93 | 420 | 1240 | 17103 | 2981 | 1007 | 2.37 | 40.72 | 47.25 | |
8 | Dose-Response | journal | 0.727 Q2 | 48 | 100 | 105 | 4812 | 321 | 95 | 2.40 | 48.12 | 35.13 | |
9 | Journal of Medical Toxicology | journal | 0.713 Q2 | 58 | 43 | 207 | 958 | 384 | 173 | 1.89 | 22.28 | 41.15 | |
10 | Toxicology Reports | journal | 0.674 Q3 | 64 | 148 | 353 | 6998 | 999 | 350 | 2.67 | 47.28 | 45.45 | |
11 | American Journal of Pharmaceutical Education | journal | 0.630 Q1 | 78 | 167 | 565 | 3694 | 839 | 475 | 1.36 | 22.12 | 62.81 | |
12 | Artificial Cells, Nanomedicine and Biotechnology | journal | 0.582 Q2 | 86 | 552 | 511 | 24774 | 1844 | 509 | 3.81 | 44.88 | 39.85 | |
13 | Advances in Pharmacological Sciences | journal | 0.577 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
14 | Journal of Immunotoxicology | journal | 0.574 Q3 | 48 | 15 | 172 | 723 | 355 | 171 | 2.06 | 48.20 | 48.84 | |
15 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.539 Q2 | 88 | 47 | 138 | 2085 | 279 | 137 | 1.61 | 44.36 | 37.31 | |
16 | Current Therapeutic Research | journal | 0.531 Q3 | 46 | 14 | 54 | 373 | 92 | 50 | 1.79 | 26.64 | 31.75 | |
17 | Contemporary Clinical Trials Communications | journal | 0.453 Q3 | 26 | 106 | 194 | 3628 | 205 | 191 | 1.08 | 34.23 | 50.57 | |
18 | OpenNano | journal | 0.404 Q2 | 21 | 7 | 12 | 333 | 30 | 12 | 2.50 | 47.57 | 33.33 | |
19 | Molecular and Cellular Pharmacology | journal | 0.366 Q2 | 28 | 0 | 10 | 0 | 13 | 8 | 0.00 | 0.00 | 0.00 | |
20 | Natural Product Communications | journal | 0.275 Q3 | 63 | 398 | 1468 | 11259 | 1078 | 1426 | 0.58 | 28.29 | 41.25 | |
21 | International Journal of Medicinal Chemistry | journal | 0.164 Q4 | 4 | 0 | 4 | 0 | 2 | 4 | 0.67 | 0.00 | 0.00 | |
22 | Pharmaceutical Technology | journal | 0.152 Q3 | 42 | 228 | 588 | 965 | 89 | 202 | 0.15 | 4.23 | 36.63 | |
23 | Journal of Excipients and Food Chemicals | journal | 0.101 Q4 | 17 | 12 | 29 | 264 | 11 | 18 | 0.50 | 22.00 | 41.94 | |
24 | Accounting (discontinued) | journal | 18 | 6 | 0 | 216 | 0 | 0 | 0.00 | 36.00 | 35.71 | ||
25 | Mental Health Clinician | journal | 23 | 53 | 138 | 1246 | 42 | 138 | 0.32 | 23.51 | 64.57 | ||
26 | Neuropsychopharmacology Reports | journal | 22 | 29 | 11 | 944 | 0 | 11 | 0.00 | 32.55 | 26.76 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®